Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the ...

Hearing on weight loss drug prices will feature CEO of Novo Nordisk and comes after threats to subpoena company executives.

Novo Nordisk acquired monlunabant in a $1bn deal last year, but the Phase IIa trial raises questions over the efficacy and ...

The House and Senate are racing to complete the government funding process with the Sept. 30 shutdown deadline looming and lawmakers eager to head back to their districts to campaign ahead of the ...

The Buncombe County Board of Commissioners approved reallocating millions in ARPA funds to three groups supporting people experiencing homelessness.

Danish Prime Minister Mette Frederiksen said she’s “extremely proud” of the country’s corporate champions, and rejected concerns that any downturn at pharma giant Novo Nordisk A/S would destabilize ...

Danish Prime Minister Mette Frederiksen says that she is "not really worried" about the size of firms like Novo Nordisk. "I ...

Novo Nordisk's chief executive is preparing for a showdown next week with U.S. Senator Bernie Sanders over the high price of ...

Global GLP-1 Analogues Market is valued at approximately USD 35.59 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 33% over the forecast period 2024-2032. Read the ...

Ozempic is a popular diabetes drug that is also used for weight loss by suppressing appetite. Sanders expressed confidence ...

Novo Nordisk A/S’s obesity shot Wegovy also prevents strokes, heart attacks and death. The price of those benefits is far ...

Recent health news highlights key regulatory approvals and legal actions. The EU backs Novo Nordisk's Wegovy for an ...